A new study by LMU and Helmholtz Munich shows how pathogens control changes in their cell surface to evade the immune system.
Almirall partners with etherna; Daiichi’s RNA deal with Depixus; SQZ founder’s startup emerges from stealth
Plus, news on Antabio’s €25 million Series B, Athira’s Alzheimer’s data, Connect’s asthma results and Liquidia’s $25 million raise. Almirall, etherna’s new partnership: The companies